EVG.L - Evgen Pharma plc
LSE - LSE Delayed price. Currency in GBp
Show:
Annual
Income statement
Currency in GBP. All numbers in thousandsBreakdown
ttm
31/03/2019
31/03/2018
31/03/2017
31/03/2016
Total revenue
-
0
-
-
-
Cost of revenue
-
-
-
-
-
Gross profit
-
-
-
-
-
Operating expenses
Research development
-
1,689
-
-
-
Selling general and administrative
-
499
-
0
0
Total operating expenses
2,943
3,120
3,026
3,658
2,434
Operating income or loss
-2,943
-3,120
-3,026
-3,658
-2,434
Interest expense
-
-
0
3
791
Total other income/expenses net
-
-
-
-
-
Income before tax
-2,943
-3,120
-3,026
-3,644
-3,217
Income tax expense
-501
-496
-443
-576
-85
Income from continuing operations
-2,442
-2,624
-2,583
-3,068
-3,132
Net income
-2,442
-2,624
-2,583
-3,068
-3,132
Net income available to common shareholders
-2,442
-2,624
-2,583
-3,068
-3,132
Reported EPS
Basic
-
-0.03
-0.03
-0.04
-0.06
Diluted
-
-0.03
-0.03
-0.04
-0.06
Weighted average shares outstanding
Basic
-
95,857
78,697
73,153
49,798
Diluted
-
95,857
78,697
73,153
49,798
EBITDA
-
-3,099
-3,005
-3,624
-2,418